Galina Goloverda PhD

Galina Goloverda PhD

Professor

A Theranostic Agent Construction:     Development of New Strategies for Peptide Conjugation.

We are developing novel magnetic theranostic agents based on ultra-small superparamagnetic nanoparticulate maghemite covered with covalently attached non-polymeric amphiphilic organic shell.  Organic shell termini are being conjugated with a peptide for cancerous cells’ recognition.

Selected Publications:

(a) Tenacic Acids: a New Class of Tenacious Binders to Metal Oxide Surfaces. Rajesh Komati, Carl Mitchell, Anastasia LaBeaud, Huy Do, Galina Goloverda and Vladimir Kolesnichen-ko, Chemistry-A European Journal, 2018, 24, 14824-14829.

(b) A Versatile Method of Ambient-Temperature Solvent Remov-al. Igor Kolesnichenko, Galina Goloverda and Vladimir Kole-snichenko, Organic Process Research & Development, 2020, 24, 25-31.

Topics & Keywords: Organic Linkers, Superparamagnetic nanoparticles, Cell labels, MRI Contrast Agents

ORCID: https://orcid.org/0000-0002-4903-8005

NCBI: http://www.ncbi.nlm.nih.gov/sites/myncbi/1xM95ZtRbOyQ/bibliography/48732709/public/?

LCRC Faculty

Donna Ryan MD
Population Sciences
Pennington Biomedical Research Center
Nakhle Saba MD
Translational Oncology
Our Lady of the Lake / LSU Health
Hana Safah, MD
Translational Oncology
Our Lady of the Lake / LSU Health
Maria Sanchez-Pino PhD
Cancer Biology
LSU Health - New Orleans
Dr. Oliver Sartor
Translational Oncology
Tulane University School of Medicine
Suzana Savkovic PhD
Cancer Biology
Tulane University School of Medicine
Tiffany N. Seagroves PhD
Cancer Biology
Tulane University School of Medicine
Qiang Shen MD PhD
Translational Oncology
LSU Health - New Orleans
Guillaume Spielmann, PhD
Genes X Environment
LSU A&M- Baton Rouge